Brief: Artivion Initiates Enrollment In Persevere Clinical Trial
27/07/2022 13:27
Artivion Inc AORT.N :
* ARTIVION INITIATES ENROLLMENT IN PERSEVERE CLINICAL TRIAL
Source text for Eikon: ID:nPn2mvRKMa
Further company coverage: AORT.N
Recent news on Artivion
See all newsUS RESEARCH ROUNDUP-Axon Enterprise, Williams-Sonoma, Xcel Energy
Artivion Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: Artivion Q2 Revenue USD 125.757 Million Vs. IBES Estimate USD 120 Million
U.S. RESEARCH ROUNDUP-Applied Materials, McDonald's, McKesson
Artivion Q1 revenue slightly beats, cuts 2026 outlook